Erenumab matching placebo + ERENUMAB for migraine disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Feb 2019: Trial registered, NCT03828539
  2. 22 Feb 2019: Trial started, NCT03828539

The trials

NCT03828539: Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine

State
Completed
Phase
Phase 4
People
777 taking part
Started
22 Feb 2019
Primary completion
29 Jul 2020
Arms
Erenumab
Results
Posted on the registry
  1. 4 Feb 2019: Trial registered
  2. 22 Feb 2019: Trial started
  3. 29 Jul 2020: Trial completed
  4. 9 Aug 2021: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.